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Events during follow-up
Death Recurrent Ischemia
lower transvalvular pressure gradients little benefit in exercise performance
is achieved with p-blocker therapy in patients with moderately severe mitral
stenosis.
Multivariate analysis identified BBT as an independent predictor of long-
term survival in the t-PA arm, but not the PTCA arm. In PTCA pts, BBT was
a univariate predictor of the combined end point of freedom from death,
infarction, heart failure and dysrhythmias.
Conclusion: BBT appears to provide significant beneficial effects during
long-term follow-up after t-PA for acute MI; these benefits were less impres-
sive and not statistically significant in the PTCA-treated patients.
Leszek Ceremuiynski 1, Andrzej Budaj, Wanda Smielak-Korombel, Jerzy Kuch,
Maria Krzeminska-Pakula, Janusz Maciejewicz, Edmund Nartowicz, Teresa Zaleska,
Andrzej Dyduszynski, Piotr Kokowicz, collaborating centers of Polish Amiodarone
Trial. 1Postgraduate Medical School, Grochowski Hospital, Warsaw. PI
The Polish Amiodarone Trial revealed significant reduction of l-year cardiac
mortality with low-dose Amiodarone (Am) after MI. To assess whether this
beneficial effect persisted, the long-term outcomes of the pts of the Am
treated group (n = 305) and ofthe control group (C) (n = 309) were assessed.
The probability of cardiac death after 12 and 46 months according to
Kaplan-Meier curves was respectively Am 6.2,17.4% and C 10.7, 19.5%.
The curves after 12 months remained parallel.
The comparison of 25 pts treated continuosly for 46 months with Am
and 189 C pts not treated with Am revealed significant difference in survival
curves in favour of Am treated group (p = 0.04).
Side effects occurred in 3 of 25 pts treated with Am during long-term
follow-up.
Beneficial effect of one year Am treatment on survival after Mi persists for
the next three years. The prolongation of therapy is feasible and diminishes
the risk of cardiac death.
Long-term Secondary Prevention After
Myocardial Infarction with Amiodarone
We conclude 1) PMC with IN provides better immediate results than DB.
mainly because of a tendency towards less frequent severe MR. 2} Never-
theless, no difference in functional results is apparant at 2 years,
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Comparison of Immediate and Mid-term Results
Following Percutaneous Mitral Commissurotomy
with the Inoue Stepwise Technique and with the
Double-Balloon Technique
Long Term (6 year) Outcome After Catheter
Balloon Valvuloplasty in Patients with Mitral
Stenosis
Increase in VA (2D echo) (cm2)
MR '" 314 (Sellers) (%)
Good immediate results (%)
Good results at 2 years (%)
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Bernard lung, Bertrand Cormier, Olivier Nallet. Jean-Marc Porte,
Pierre-Louis Michel, Jean Acar, Alec Vahanian. Tenon Hospital. Paris. France
Immediate and mid-term results of percutaneous mitral commissurotomy
(PMC) were compared following the use of the Double-Balloon technique
(DB) and the Inoue stepwise technique (IN) under echo-guidance. Between
1986 and 1994, 1228 patients (pts) underwent PMC in our department. 586
pts with DB and, more recently, 642 pts with IN.
Before PMC, no significant difference was found between the two groups
as regards clinical or echocardiographic or hemodynamic data.
Good immediate results were defined as a final valve area (VA) ~1.5 cm2
without mitral regurgitation (MR) >2/4. Good results at 2 years were defined
as survival without operation and with continuing good functional results
INYHA class I or II}.
Results were as follows:
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Beta-Adrenergic Blockade in Patients with
Moderate Mitral Stenosis
Brett C. Stoll, Thomas L. Ashcom, Joseph P. Johns, James E. Johnson, Bernard
J. Rubal. Brooke Army Medical Center, Fort Sam Houston. TX 78234-6200
p-blocker therapy remains controversial in patients with mitral stenosis. In
this randomized, double-blinded, crossover, placebo-controlled study, the ef-
fects of atenolol (50 and 100 mglday) were assessed in 15 patients (age =
46 ± 11 yrs) with moderate mitral stenosis (mitral valve area = 1.0 ± 0.4
cm2; NYHA class II-III) at rest (R) and during upright bicycle ergometry IE}.
Doppler-echocardiography was employed to compare heart rate IHR), car-
diac (CI) and stroke volume (SVI) indices, diastolic filling period (DFP), and
peak and mean (Mn Grad) transmitral gradients; a metabolic cart was used
to obtain maximum V02, VC02 and anaerobic threshold (AT). P-blockade
therapy did not improve exercise time, extemal work, max V02 or AT. During
exercise, max V02 and CI decreased (p < 0.05) > 11 % and >20%, respec-
tively, with atenolol. Thefollowing hemodynamic data are presented as mean
±sd:
Sharon Orrange, David Kawanishi, Becky Lopez. Susan Curry,
Shahbudin Rahimtoola. University ofSo. Califorma. Los Angeles. CA
Catheter balloon valvuloplasty (CBV) for mitral stenosis was performed in
132 patients (pts) from 1986 to '94. There were 104 women 179%) and 28
men, aged 44 ± 14 years. Pre-CBV, 12 pts were NYHA Functional Class (FC)
IV, 87 in FC III. 28 FC II and 2 were FC I. CBV increased mitral valve area IMVA)
from 0.98 ± 0.26 to 1.94 ± 0.57 cm2, p < 0.001.
There were 6 early deaths up to 1 month ("procedure-related"); all 4 late
deaths occurred after elective valve replacement (VR) was performed 18.2
± 25 months later. Actuarial 6 yr survival was 83 ± 6% when mortality after
VR is included, excluding these 6 yr survival was 95 ± 1%. Actuarial 1, 3 and
6 yr event-free survival (survival without VR or repeat CBV) were 80 ± 4%,
76 ± 4% and 63 ± 7%. Pre-CBV variables were not significant predictors of
outcome. On multivariate analysis, post-CBV independent predictors of 6 yr
event-free survival were 1) MVA ~1.5 vs < 1.5 cm2, 73 ± 8% vs 32 ± 12%; 2}
Pulmonary artery (PA) wedge .:::18 vs > 18 mmHg, 84 ± 6% vs 38 ± 12%, P
< 0.001 for both. Pts. with MVA ~ 1.5 cm2 In = 96) could be further divided
into high and low-risk subgroups for 6 yr event-free survival by 3 post-CBV
variables: 11 PA wedge .:::18 vs > 18, 90 ± 6% vs 46 ± 15% (p = 0.002); 2)
Mean PA <30 vs ~30, 89 ± 6% vs 54 ± 14% (p = 0.061; 3) Cardiac Index (CI)
~2.5 vs <2.5.82 ± 8% vs 53 ± 17% (p = 0.002). Pts with post-CBV MVA
<1.5 In = 24) had no additional predictors of event-free survival. Of those
pts who did not undergo VR or repeat CBV 94% were FCI or FCII.
Conclusions: CBV for mitral stenosis has good long term results up to 6
yrs. Late deaths were related to elective surgery. 6 yr event-free survival was
very good in pts with post-CBV MVA ~1.5 cm2 especially if PA wedge was
.:::18 or CI was ~2.5.
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Placebo Atenolol
50 mg 100 mg
HR R 76 ± 13 60 ± 11' 58 ± 13'
(bpm) E 144 ± 15 112± 23' 103 ± 21'
DFP R 431 ± 97 604 ± 148' 629 ± 175'
1msec) E 208 ± 35 277 ± 90' 300 ± 95'
SVI R 22 ± 7 22 ± 6 26 ± 8
Imllm2) E 21 ± 10 22 ± 10 26 ± 9
Mn Grad R 5 ± 4 4± 3 4± 2
(mmHg) E 20 ± 8 17± 8 15 ± 8'
'p < 0.05 Placebo vs Atenolol
Although HR and Mn Grad decreased and DFP increased with atenolol,
SVI changed little compared with placebo. The data suggest that in spite of
Late Cardiac Catheterization Results of Catheter
Balloon Commissurotomy for Mitral Stenosis at
Rest and Exercise
DaVid Kawanishi, Becky Lopez, Sharon Orrange, Susan Curry,
Shahbudin Rahimtoola. University ofSouthern California. Los Angeles. CA
Cardiac catheterization (cath) was performed on 132 patients (pts) both pre
and immediately post catheter balloon commissurotomy ICBC). Sixty eight
pt's had cath performed at 3--B months post-CBC and twenty had a late
follow-up cath (mean 3.2 yrs. range 1-7 yrs). At late follow-up cath 16 of the
20 pts were NYHA functional class (FC) I or II; 13 females and 3 males age 40
± 11 yrs, We have reviewed the sequential hemodynamic findings in these
16 pt's to see if hemodynamic improvement achieved by CBC is sustained.
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'p-value :5 0.05 For 3-6 month and Late follow-up vs. Immediate post CBC (ANOVA With
repeated measures)
Conclusion: Patients who are clinically stable (FC I or II) show sustained im-
provement in hemodynamics and En immediately post-CBC to an average
of 3.2 yrs later; LV size and function remains normal.
Wound Healing in the Mitral Valve
Level BAV Normals p
Anulus 2.36 ± 0.31 2.27 ± 0.29 NS
Sinuses of Valsalva 3.16 ± 0.38 2.90 ± 0.32 <0.01
Supraaortic ridge 264 ± 0.46 2.50 ± 0.28 003
Proximal Ascending Aorta 3.12 ± 0.48 2.71 ± 029 <0.01
11024-821
Animal studies have demonstrated that ventilation can be deferred for sev-
eral minutes in witnessed arrest if chest compression is initiated promptly.
It is unknown if this observation is also valid in situations of a "prolonged
down time". To assess whether immediate ventilation was essential follow-
ing a prolonged down time arrest, six 20-30 kg, dogs were studied following
ventricular fibrillation (VF). Chest compression (no ventilation) at S0-90/min
was initiated after 6 min. Aortic pressure (pr) and blood gases were moni-
tored. Pre-VF aortic pr; pH: PC02 and 02 saturation (%02 sat) at room air
Hospital in Verona by 2D echocardiography with PW, CW and Color Doppler.
Seventy subjects, comparable for age (17.82 ± 0.7, range 17-19) and body
surface area (1.79 ± 0.09 vs 1.82 ± 0.08, respectively) without clinical and
echocardiographic evidence of cardiac abnormalities, were used as control
group. Aortic root dimensions were measured by 2D-echocardiography at
four levels: 1) anulus, 2) sinuses on Valsalva, 3) supraaortic ridge and 4) prox-
imal ascending aorta.
Results (mean ± SD):
Conclusion: Aortic root dimensions are significantly greater in young men
with normally functioning BAV than in control subjects comparable for gen-
der, age and body size. Noticeably, the aortic root dimensions in patients with
BAV are still within the range of normality. These data confirm the hypothe-
sis that BAV and aortic dilation are expression of a common developmental
defect.
Koichi Tamura, Michael Jones, Izumi Yamada, Victor J. Ferrans. National Heart
Lung and Blood Institute, NIH, Bethesda, MD
To study the healing of wounds in cardiac valves, histologic and ultrastruc-
tural studies were performed in the mitral valves of 10 sheep in which a 1
cm long, radially oriented incision had been made at the center of the free
edge of the anterior mitral leaflet. Two types of granulation tissue (GT) were
associated with healing of these wounds. The first covered the cut edge and
consisted of myxomatous tissue that extended from the valvular spongiosa
and fibrosa. Maturation of collagen, with formation of thick bundles of fib-
rils progressed for up to 16 weeks in this tissue, extending from the basal
portion of the wound toward the free edge of the leaflet. The second type
of GT resembled that seen in areas of reactive fibrosis in regurgitant mitral
valves. It was found predominantly on the ventricular surfaces of the leaflets,
also extending from their basal portion. At 4-5 weeks, fibroblasts were the
only cellular components of GT. Parallel arrays of myofibroblasts were found
after S weeks. The GT also contained a network of proteoglycan granules,
which were more abundant in the ventricular side and increased in amount
up to the 12th week, decreasing thereafter. The cut surface was relined by
growth and spreading of endothelial cells from both sides of the leaflet. This
process began at the most basal region of the wound and was completed
at S weeks.
Neovascularization was observed in the basal regions of the wounds at 12
weeks. The new vascular structures sprouted from vessels normally present
in the spongiosa along the valve ring, and initially consisted of cords of en-
dothelial cells that were surrounded by basement membranes, pericytes and
some elastic fibers, but lacked distinct lumina. At 16 weeks, similar vessels
extended along the distal area of the wound. In conclusion, the healing of
mitral valvular wounds is a slow process that requires 8-12 weeks forthe for-
mation of a dense collagenous scar at the edges and complete restoration of
the endothelial lining. Progression of healing is associated with the pheno-
typic modulation of connective tissue cells from fibroblast to myofibroblasts
and neovascularization of the valvular spongiosa.
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Immediate Ventilation Questioned Even with
Long Downtime Cardiopulmonary Resuscitation
NIsha C. Chandra, Henry R. Halperin, David M. Blair. Joshua E. Tsitlik. Johns
Hopkins Medicallnstitub'ons, Baltimore, MD
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Aortic Dilation in Young Males with Isolated
Normally Functioning Bicuspid Aortic Valve
Variable Baseline Immed. Post 3-6 Month 3.2 yrs
mean ± SO mean ± SO mean ± SO mean ± SO
CI (FICKj-REST 2.8 ± 6 33±08 3.2 ± 0.7 33±10
CI (FICKI-EXER 3.7 ± 0.8 50±06 48 ± 1.1
MVG-REST 16.2 ± 5.6 5.0 ± 1.9' 6.9 ± 32' 8.3 ± 4.7
MVG-EXER 27.1 ± 5.6 18.2 ± 5.7 15.5 ± 76
PAW-REST 28 ± 6.9 15.8 ± 3.8' 18.2 ± 6.8' 21.4 ± 5.8
PAW-EXER 45.5 ± 9.6 290 ± 8.1 29.6 ± 8.9
MVA-REST 1.1 ± 0.3 23 ± 0.6 20 ± 0.7 20 ± 0.7
MVA-EXER 1.1 ± 0.3 2.4 ± 0.7 23 ± 0.9
mPA-REST 433 ± 13.4 33.1 ± 9.8 28.3 ± 102 313 ± 10.2
mPA-EXER 64.8 ± 21.4 43.1 ± 11.6 419±15.7
LVEOVI 73.3 ± 18.2 79.6± 17.2 82.7 ± 21.3 79.3 ± 13.8
LVEF 0.58 ± 0.06 0.60 ± 0.06' 0.59 ± 0.10' 0.68 ± 0.06
En TIMES (SEC) 442 ± 180 596 ± 114 520 ± 158
Mitral Stenosis and Pregnancy: Balloon
Valvuloplasty Against Open Comissurotomy
Daniel Born, Jose A. Souza, Antonio C. Carvalho, Orlando Campos, Julio
C. Massoneto, Antonio F. Moron, Joao N. Branco, Enio BUffolo, Dirceu V Santos,
Eul6gio Martinez. Escola Paulista de Medicina, Sao PaUlo, Brazil
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Maternal cardiac disease is among the most significant causes of non-
obstetric mortality during pregnancy. Mitral stenosis (MS) is the most fre-
quent valvular disease in women of childbearing age. We reviewed our ex-
perience of 636 cases of cardiac disease during pregnancy out of which 363
had rheumatic heart disease and 151 had MS. Forty pts with MS undervvent
an intervention during pregnancy due to cardiac failure (36 pts) or hemopt-
ysis (4 pts). Open comissurotomy with high flow and without hypothermia
was performed in 24 pts in the last thirteen years, gestational age varying
from 4 to 30 weeks, anoxia from 7 to 28 minutes and perfusion time from
12 to 41 minutes. One woman and her fetus died due to coagulopathy in
the intraoperative period; no further maternal morbidity occurred but there
were 4 other fetal deaths in the immediate postoperative period, prematu-
rity was 40% and small for gestational age 13.3% in 15 newborns delivered
at our hospital. Sixteen pts undervvent mitral balloon valvuloplasty (MBV) in
the last three years, gestalional age varying from 5 to 34 weeks with an av-
erage Block score of 7. All of them improved the mitral valve area by more
than 50%, mean area by echo-Doppler increasing from 0.9 to 1.8 cm2 with
the mean left atrium-LV gradient falling from 19.0 to 5.0 mmHg. Mitral in-
SUfficiency was rated as ++/++++ in 2 pts and pericardial perforation oc-
curred in 3 pts without tamponade. Maternal mortality was 0% and no pt had
to go to surgery during pregnancy but there was 1 fetal death (6.2%); one
premature and one baby small for gestational age occurred in the other 15
deliveries. MBV compares favourably against open comissurotomy in preg-
nantwomen with MS concerning: maternal death (0.0% x 4.1 %). fetal death
(6.2% x 20.8% - P < 0.05). prematurity (6.2% x 40.0% - P < 0.05) and
small for gestational age (6.2% x 13.3%). MBV is now the procedure of
choice at our institution for pts with MS that require an intervention during
pregnancy.
Stefano Nislri 1, Maria Domenica Sorbo " Marco Marin 2, Monica Palisi 2,
Roldano Scognamiglio 2. 1Militay Hospital, Verona; 2Department of Cardiology,
Padua
Bicuspid aortic valve (BAV) is a common congenital disorder frequently coex-
isting with abnormalities of the aortic arch inclUding aortic coarctation, dis-
secting aneurysm and aortic root dilation: it has been suggested that these
associations result from a common developmental defect. Moreover, aortic
root dimensions are influenced by age and body size; thus, in order to test
the hypothesis of a common congenital disorder underlying BAV and aortic
dilation, we prospectively studied young males with isolated, normally func-
tioning bicuspid aortic valve during the medical examinations for the military
service, in comparison with a age-matched group with no cardiovascular ab-
normalities.
Sixty-three patients (aged 17.8 ± 0.6 year, range 17-19) whose echocar-
diograms showed a normally functioning BAV were studied at the Military
The following parameters were measured: mitral valve gradient (MVG). mean
pulmonary artery wedge (PAW), mean pulmonary artery pressure (PA), Fick
cardiac index (CI). mitral valve area (MVA), left ventricular (LV) end-diastolic
volume index (EDVI) and LV ejection fraction (EF). Exercise treadmill times
(En) were also recorded.
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